Skip to content

Clinical Characteristics and Outcomes of Coronary Heart Disease

Clinical Characteristics and Outcomes of Coronary Heart Disease: a Prospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06335901
Acronym
IMPROVE
Enrollment
20000
Registered
2024-03-28
Start date
2020-02-01
Completion date
2022-04-30
Last updated
2025-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Brief summary

This study evaluated and compared the prognostic value of different Baseline data and clinical variables to develop predictive model in patients with CHD.

Interventions

DRUGDrug:Standard therapy

Percutaneous coronary Intervention

Sponsors

Xinjiang Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

1. Patients diagnosed with Coronary Heart Disease (CHD) admitted to the First Affiliated Hospital of Xinjiang Medical University. 2. The diagnosis is based on clinical assessments, including symptomatic evaluation, electrocardiographic findings, and coronary angiography.

Exclusion criteria

We excluded patients who had serious heart failure, malignant tumor,rheumatic heart disease, valvular heart disease, congenital heart disease, pulmonary heart disease and serious dysfunction of the liver or kidney.

Design outcomes

Primary

MeasureTime frame
Death (All-cause mortality、Cardiac mortality )5 years of follow-up deaths occurred during this period

Secondary

MeasureTime frame
Major adverse cardiovascular events5 years of follow-up deaths occurred during this period

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026